Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy & Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent & Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

NCT00563056 is registered in ClinicalTrials.gov with Mundipharma Research Limited as lead sponsor.

NCT NCT00563056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00563056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy & Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent & Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma
Lead sponsor
Mundipharma Research Limited
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
April 30, 2008
Enrollment
227 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

asthma bronchiale